53 related articles for article (PubMed ID: 32576020)
1. Outcomes of adjuvant whole-brain radiotherapy versus hypofractionated stereotactic radiotherapy after surgical resection of brain metastases: a propensity score-matched analysis.
Keller A; Lefebvre F; Ricard D; Noël G; Antoni D
Chin Clin Oncol; 2020 Aug; 9(4):55. PubMed ID: 32576020
[TBL] [Abstract][Full Text] [Related]
2. Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection.
Bilger A; Bretzinger E; Fennell J; Nieder C; Lorenz H; Oehlke O; Grosu AL; Specht HM; Combs SE
Cancer Med; 2018 Jun; 7(6):2350-2359. PubMed ID: 29745035
[TBL] [Abstract][Full Text] [Related]
3. Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis.
Jensen CA; Chan MD; McCoy TP; Bourland JD; deGuzman AF; Ellis TL; Ekstrand KE; McMullen KP; Munley MT; Shaw EG; Urbanic JJ; Tatter SB
J Neurosurg; 2011 Jun; 114(6):1585-91. PubMed ID: 21166567
[TBL] [Abstract][Full Text] [Related]
4. Multicenter analysis of stereotactic radiotherapy of the resection cavity in patients with brain metastases.
Combs SE; Bilger A; Diehl C; Bretzinger E; Lorenz H; Oehlke O; Specht HM; Kirstein A; Grosu AL
Cancer Med; 2018 Jun; 7(6):2319-2327. PubMed ID: 29696815
[TBL] [Abstract][Full Text] [Related]
5. Multi-institutional Analysis of Prognostic Factors and Outcomes After Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients With Brain Metastases.
Eitz KA; Lo SS; Soliman H; Sahgal A; Theriault A; Pinkham MB; Foote MC; Song AJ; Shi W; Redmond KJ; Gui C; Kumar AMS; Machtay M; Meyer B; Combs SE
JAMA Oncol; 2020 Dec; 6(12):1901-1909. PubMed ID: 33057566
[TBL] [Abstract][Full Text] [Related]
6. Postoperative stereotactic radiosurgery and hypofractionated radiotherapy for brain metastases using Gamma Knife and CyberKnife: a dual-center analysis.
Kübler J; Wester-Ebbinghaus M; Wenz F; Stieler F; Bathen B; Mai SK; Wolff R; Hänggi D; Blanck O; Giordano FA
J Neurosurg Sci; 2024 Feb; 68(1):22-30. PubMed ID: 32031357
[TBL] [Abstract][Full Text] [Related]
7. Propensity score-matched analysis comparing hippocampus-avoidance whole-brain radiotherapy plus simultaneous integrated boost with hippocampus‑avoidance whole-brain radiotherapy alone for multiple brain metastases-a retrospective study in multiple institutions.
Wang X; Chen J; Lei Z; Chen H; Zhang Y; Liu G; Li S; Zheng Z; Wang H
BMC Cancer; 2023 Aug; 23(1):796. PubMed ID: 37620791
[TBL] [Abstract][Full Text] [Related]
8. Staged radiosurgery alone versus postoperative cavity radiosurgery for patients with midsize-to-large brain metastases: a propensity score matching analysis.
Yomo S; Yako T; Kitazawa K; Oguchi K
J Neurosurg; 2022 Aug; 137(2):555-562. PubMed ID: 34920421
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated and single-fraction radiosurgery for brain metastases with sex as a key predictor of overall survival.
Mangesius J; Seppi T; Bates K; Arnold CR; Minasch D; Mangesius S; Kerschbaumer J; Lukas P; Ganswindt U; Nevinny-Stickel M
Sci Rep; 2021 Apr; 11(1):8639. PubMed ID: 33883632
[TBL] [Abstract][Full Text] [Related]
10. Repeated Stereotactic Radiotherapy for Local Brain Metastases Failure or Distant Brain Recurrent: A Retrospective Study of 184 Patients.
Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Mazzara C; Cebula H; Noel G; Antoni D
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894315
[TBL] [Abstract][Full Text] [Related]
11. Results of hypofractionated stereotactic radiotherapy for resected and intact large brain metastases.
Vetlova ER; Banov SM; Golanov AV; Pronin IN; Antipina NA; Galkin MV
Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(6):67-75. PubMed ID: 38054229
[TBL] [Abstract][Full Text] [Related]
12. Socio-economic disparities influence likelihood of post-operative radiation to resection cavities of metastatic brain tumors.
Haider G; Dadey DYA; Rodrigues A; Pollom EL; Adler JR; Veeravagu A
Acta Neurochir (Wien); 2023 Dec; 165(12):4253-4258. PubMed ID: 37816918
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative or postoperative stereotactic radiotherapy for brain metastases: time to systemic treatment onset and other patient-relevant outcomes.
Dejonckheere CS; Layer JP; Hamed M; Layer K; Glasmacher A; Friker LL; Potthoff AL; Zeyen T; Scafa D; Koch D; Garbe S; Holz JA; Kugel F; Grimmer M; Schmeel FC; Gielen GH; Forstbauer H; Vatter H; Herrlinger U; Giordano FA; Schneider M; Schmeel LC; Sarria GR
J Neurooncol; 2023 Sep; 164(3):683-691. PubMed ID: 37812290
[TBL] [Abstract][Full Text] [Related]
14. Intraoperative radiotherapy after resection of brain metastases located in the posterior fossa. Analysis of postoperative morbidity and mortality in a single center cohort.
Krauss P; Kahl KH; Bonk MN; Wolfert C; Sommer B; Stueben G; Shiban E
J Clin Neurosci; 2023 Dec; 118():1-6. PubMed ID: 37832264
[TBL] [Abstract][Full Text] [Related]
15. Incidence of hippocampal and perihippocampal brain metastases and impact on hippocampal-avoiding radiotherapy: A systematic review and meta-analysis.
Wiegreffe S; Sarria GR; Layer JP; Dejonckheere E; Nour Y; Schmeel FC; Anton Giordano F; Schmeel LC; Popp I; Grosu AL; Gkika E; Stefaan Dejonckheere C
Radiother Oncol; 2024 May; 197():110331. PubMed ID: 38772476
[TBL] [Abstract][Full Text] [Related]
16. A genomic score to predict local control among patients with brain metastases managed with radiation.
Lamba N; Cagney DN; Catalano PJ; Kim D; Elhalawani H; Haas-Kogan DA; Wen PY; Wagle N; Aizer AA
Neuro Oncol; 2023 Oct; 25(10):1815-1827. PubMed ID: 37260393
[TBL] [Abstract][Full Text] [Related]
17. Brain metastases from ovarian carcinoma.
Piura E; Piura B
ISRN Oncol; 2011; 2011():527453. PubMed ID: 22191058
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases.
Alhalabi O; Soomro Z; Sun R; Hasanov E; Albittar A; Tripathy D; Valero V; Ibrahim NK
NPJ Breast Cancer; 2021 Mar; 7(1):28. PubMed ID: 33742001
[TBL] [Abstract][Full Text] [Related]
19. Automatically tracking brain metastases after stereotactic radiosurgery.
Hsu DG; Ballangrud Å; Prezelski K; Swinburne NC; Young R; Beal K; Deasy JO; Cerviño L; Aristophanous M
Phys Imaging Radiat Oncol; 2023 Jul; 27():100452. PubMed ID: 37720463
[TBL] [Abstract][Full Text] [Related]
20. CDKN2A/B co-deletion is associated with increased risk of local and distant intracranial recurrence after surgical resection of brain metastases.
Morshed RA; Nguyen MP; Cummins DD; Saggi S; Young JS; Haddad AF; Goldschmidt E; Chang EF; McDermott MW; Berger MS; Theodosopoulos PV; Hervey-Jumper SL; Daras M; Aghi MK
Neurooncol Adv; 2023; 5(1):vdad007. PubMed ID: 36915611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
